Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-01-26, Stock:JNJ, The news for the past five days is as follows:
2021-01-19: NEWS1: Healthcare Stocks Appear Set to Move Higher.NEWS2: Bank Of America And Goldman Sachs Results In Focus Along With Yellen Hearing.
2021-01-20: NEWS1: Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know.NEWS2: Biden Agenda, Intel Profit, Jobless Claims: 3 Things to Watch.
2021-01-21: NEWS1: FDA approves first long-acting HIV drug combination.NEWS2: Johnson & Johnson Vaccine Data Almost Ready for Analysis: Fauci.NEWS3: Hungary Approves Russia’s Covid-19 Vaccine.NEWS4: Is JNJ Stock A Buy As It Nears Phase 3 Covid Vaccine Test Results?.NEWS5: With fewer resources, rural America tackles Covid-19 vaccine distribution.
2021-01-22: NEWS1: Dow Jones Dips As Intel, IBM Weigh; Nasdaq Hits New High Ahead Of Apple Earnings.NEWS2: Top Coronavirus Vaccine Makers Will Earn Up to $23 Billion in Revenue This Year, Says New Analysis.NEWS3: HR tech company Workhuman looks to build employee connections amid pandemic.NEWS4: Glaxo (GSK) Gets FDA Nod for Long-Acting HIV Regimen Cabenuva.NEWS5: Johnson & Johnson Aims for 100 Million Vaccine Doses by Spring. The Stock Market Is Counting on It..NEWS6: J&J (JNJ) to Get the Ball Rolling for Pharma Q4 Earnings.NEWS7: Pharma Stock Roundup: FDA Nod to MRK, AZN, JNJ, GSK Drugs, LLY's New Antibody Deal.NEWS8: Is Novavax Stock A Buy As Pressure Mounts For More Covid Vaccines?.NEWS9: Johnson & Johnson Could Have 100 Million COVID-19 Vaccines By April, Board Member McClellan Says.NEWS10: 3 Cheap Dividend Aristocrats to Buy Right Now.
2021-01-25: NEWS1: Moderna CEO offers a bleak assessment of COVID-19: Virus to stay with the world 'forever'.NEWS2: Merck Scraps 'Inferior' Covid-19 Vaccines; But Shares Recover From Dip.NEWS3: Covid Vaccines: Here's What J&J Has To Do To Undercut Pfizer, Moderna.NEWS4: Dow Pares Big Loss, Nasdaq Hits New High As Apple Stock Rallies Ahead Of Earnings.NEWS5: It Was a Grim Morning in the Covid-19 Fight. The Market Is Looking to Johnson & Johnson for Hope..NEWS6: ‘The space is moving very quickly:’ MindMed Co-CEO on new psychedelic ETF.NEWS7: Humanigen signs manufacturing deal with Emergent for experimental COVID-19 drug.NEWS8: J&J may share findings from Phase 3 vaccine trial this week.NEWS9: University Hospital CEO on COVID-19 vaccination rollout.NEWS10: Coronavirus update: Moderna launches booster study for South African strain, Merck pulls out of vaccine race.NEWS11: Merck Scraps Development Of 'Inferior' Covid Vaccines; Shares Dip.NEWS12: Johnson & Johnson's Earnings: A Preview.NEWS13: COVID-19 Vaccine Update – New Strains and Supply Issues Remain a Concern.

Answer: Rise